- Quality and Safety: Medicines > Quality Assurance
- Quality and Safety: Medicines > Safety and Efficacy
(1995; 36 pages) [French] [Spanish]
The relationship between the investigator and the sponsor in matters such as financial support, fees, honorarium payments in kind must be stated in writing in the protocol or contract. The protocol or contract should be available to the drug regulatory authority and ethics committee on demand.